Subscribe for great stories in your community!
Tavanta Therapeutics, King of Prussia, has reached phase three of clinical trials associated with TAVT-45, a pipeline of specialty drugs to treat prostate cancer…
Before we send you to this site, please subscribe to our daily newsletter.